Boston-based Beth Israel Deaconess Medical Center joined InVivo Therapeutics' INSPIRE study.
Here are five things to know:
1. Martina Stippler, MD, director of neurotrauma in the neurosurgery division at Beth Israel Deaconess Medical Center, will serve as the site's principal investigator.
2. This site is the INSPIRE study's first Boston-area site.
3. Beth Israel Deaconess Medical Center serves as a teaching hospital of Harvard Medical School in Boston.
4. InVivo has now enrolled 25 clinical sites in the INSPIRE study.
5. The INSPIRE study tests the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.